JPH0317838B2 - - Google Patents

Info

Publication number
JPH0317838B2
JPH0317838B2 JP20544189A JP20544189A JPH0317838B2 JP H0317838 B2 JPH0317838 B2 JP H0317838B2 JP 20544189 A JP20544189 A JP 20544189A JP 20544189 A JP20544189 A JP 20544189A JP H0317838 B2 JPH0317838 B2 JP H0317838B2
Authority
JP
Japan
Prior art keywords
chloroform
residue
added
mixture
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20544189A
Other languages
Japanese (ja)
Other versions
JPH02138281A (en
Inventor
Isao Hayakawa
Yoshiaki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP20544189A priority Critical patent/JPH02138281A/en
Publication of JPH02138281A publication Critical patent/JPH02138281A/en
Publication of JPH0317838B2 publication Critical patent/JPH0317838B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Description

【発明の詳細な説明】 本発明は一般式 (式中R1は低級アルキル基を意味し、R2は低
級アルコキシル基、ヒドロキシル基またはハロゲ
ン原子を意味する)で表わされる化合物に関し、
この化合物は抗菌性化合物の製造原料として有用
である(特開昭59−1489号参照)。
[Detailed Description of the Invention] The present invention relates to the general formula (In the formula, R 1 means a lower alkyl group, R 2 means a lower alkoxyl group, a hydroxyl group or a halogen atom)
This compound is useful as a raw material for the production of antibacterial compounds (see JP-A-59-1489).

本発明の化合物の製造法を実施例で説明する。 The method for producing the compounds of the present invention will be explained in Examples.

参考例1:原料化合物の製造 2,3−ジフルオロ−6−ニトロフエノール
7.0g、エピクロルヒドリン7.0g、炭酸カリウム
15g及びヨウ化カリウム600mgをジメチルホルム
アミド150mlに加え、浴温85〜90℃で20時間撹拌
した。冷後不溶物を濾去し、濾液を減圧濃縮して
残渣をクロロホルムと水で分配した。クロロホル
ム層は水洗し、芒硝で乾燥後、溶媒を留去して残
渣をシリカゲルカラムクロマトグラフイで精製し
淡黄色油状物として2,3−ジフルオロ−6−ニ
トロフエニル・オキシラニルメチル・エーテル
6.1gを得た。
Reference example 1: Production of raw material compound 2,3-difluoro-6-nitrophenol
7.0g, epichlorohydrin 7.0g, potassium carbonate
15 g and 600 mg of potassium iodide were added to 150 ml of dimethylformamide, and the mixture was stirred at a bath temperature of 85 to 90°C for 20 hours. After cooling, insoluble matters were removed by filtration, the filtrate was concentrated under reduced pressure, and the residue was partitioned between chloroform and water. The chloroform layer was washed with water, dried over Glauber's salt, the solvent was distilled off, and the residue was purified by silica gel column chromatography to obtain 2,3-difluoro-6-nitrophenyl oxiranylmethyl ether as a pale yellow oil.
6.1g was obtained.

上記化合物15.0gおよび第二塩化スズ0.3mlを
無水メタノール60mlに加えて、2時間還流した。
溶媒を留去し残渣をクロロホルムと水で分配し、
クロロホルム層より、油状物として1−(2,3
−ジフルオロ−6−ニトロフエノキシ)−3−メ
トキシ−2−プロパノール16.1gを得た。
15.0 g of the above compound and 0.3 ml of tin(II) chloride were added to 60 ml of anhydrous methanol, and the mixture was refluxed for 2 hours.
The solvent was distilled off and the residue was partitioned between chloroform and water.
From the chloroform layer, 1-(2,3
16.1 g of -difluoro-6-nitrophenoxy)-3-methoxy-2-propanol was obtained.

上記化合物15gをアセトン150mlにとかし、氷
冷下、撹拌しつつジヨーンズ試薬(無水クロム酸
32g、水64ml、濃硫酸16mlから調製)50mgを滴下
した。同温度で30分、次で室温で2時間撹拌し
た。不溶物を除却し、アセトン、次いでクロロホ
ルムで洗つて、濾液及び洗液を合せ溶媒を留去し
た。残渣はクロロホルムと水で分配し、クロロホ
ルム層を水洗し、芒硝で乾燥後クロロホルムを留
去した。残渣をシリカゲルカラムクロマトグラフ
イで精製し、クロロホルム溶出液から融点39〜42
℃の1−(2,3−ジフルオロ−6−ニトロフエ
ノキシ)−3−メトキシ−2−プロパノン10.6g
を得た。
Dissolve 15 g of the above compound in 150 ml of acetone, stir under ice-cooling, and use Zion's reagent (chromic anhydride).
(prepared from 32 g, 64 ml of water, and 16 ml of concentrated sulfuric acid) was added dropwise. The mixture was stirred at the same temperature for 30 minutes and then at room temperature for 2 hours. Insoluble matter was removed, washed with acetone and then with chloroform, the filtrate and washing liquid were combined, and the solvent was distilled off. The residue was partitioned between chloroform and water, the chloroform layer was washed with water, dried over sodium sulfate, and then the chloroform was distilled off. The residue was purified by silica gel column chromatography and obtained from the chloroform eluate with a melting point of 39-42.
10.6 g of 1-(2,3-difluoro-6-nitrophenoxy)-3-methoxy-2-propanone at °C
I got it.

この化合物9.5gをエタノール100mlに溶かし、
ラネー・ニツケル10mlを加えて常圧で接触還元し
た。触媒を濾去し、溶媒を減圧留去後、残渣をシ
リカゲルカラムクロマトグラフイで精製し油状物
3.9gを得た。この油状物3.0gにエトキシメチレ
ンマロン酸ジエチル3.5gを加えて浴温105〜115
℃で2時間加熱した。冷後反応物をシリカゲルカ
ラムクロマトグラフイで精製し、融点81℃の
(7,8−ジフルオロ−3−メトキシメチル−2,
3−ジヒドロ−4H−1,4−ベンゾオキサジン
−4−イル)メチレンマロン酸ジエチル4.9gを
得た。
Dissolve 9.5 g of this compound in 100 ml of ethanol,
10 ml of Raney Nickel was added and catalytic reduction was carried out at normal pressure. After filtering off the catalyst and distilling off the solvent under reduced pressure, the residue was purified by silica gel column chromatography to obtain an oily substance.
3.9g was obtained. Add 3.5 g of diethyl ethoxymethylenemalonate to 3.0 g of this oil and bath temperature 105-115.
Heated at ℃ for 2 hours. After cooling, the reaction product was purified by silica gel column chromatography to obtain (7,8-difluoro-3-methoxymethyl-2,
4.9 g of diethyl 3-dihydro-4H-1,4-benzoxazin-4-yl)methylenemalonate was obtained.

実施例 (7,8−ジフルオロ−3−メトキシメチル−
2,3−ジヒドロ−4H−1,4−ベンゾオキサ
ジン−4−イル)メチレンマロン酸ジエチル3.0
gをポリリン酸エチル20gに加えて浴温120〜125
℃で1.5時間加熱した。冷後氷水を加え、析出物
をクロロホルムで抽出した。抽出液は水洗し、芒
硝で乾燥後、溶媒を留去した。残渣をシリカゲル
カラムクロマトグラフイで精製し、クロロホルム
溶出分から得られた粉末を、ジクロルメタンとイ
ソプロピルエーテルの混液から再結晶して融点
238℃の微針晶として9,10−ジフルオロ−3−
メトキシメチル−7−オキソ−2,3−ジヒドロ
−7H−ピリド[1,2,3−de][1,4]ベン
ゾオキサジン−6−カルボン酸エチル1.7gを得
た。
Example (7,8-difluoro-3-methoxymethyl-
Diethyl 2,3-dihydro-4H-1,4-benzoxazin-4-yl)methylenemalonate 3.0
Add g to 20 g of ethyl polyphosphate and bath temperature 120-125
Heated at ℃ for 1.5 hours. After cooling, ice water was added, and the precipitate was extracted with chloroform. The extract was washed with water, dried over Glauber's salt, and then the solvent was distilled off. The residue was purified by silica gel column chromatography, and the powder obtained from the chloroform elution was recrystallized from a mixture of dichloromethane and isopropyl ether to determine the melting point.
9,10-difluoro-3- as microneedles at 238℃
1.7 g of ethyl methoxymethyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate was obtained.

元素分析値 C16H15F2NO5として 計算値 C56.64,H4.46,N4.13 分析値 C56.51,H4.44,N4.02 上記化合物1.7gをジクロルメタン100mlに加え
氷冷下に臭化アルミニウム6.0gをエタンチオー
ル10mlに溶かした溶液を適下した。室温にもどし
て3時間撹拌したのち、溶媒を留去し、残渣に氷
水を加えて不溶物を濾取した。得た白色粉末をク
ロロホルムとエタノールの混液から再結晶すると
融点268〜270℃の微針晶として9,10−ジフルオ
ロ−3−ヒドロキシメチル−7−オキソ−2,3
−ジヒドロ−7H−ピリド[1,2,3−de]
[1,4]ベンゾオキサジン−6−カルボン酸エ
チル1.1gが得られた。
Elemental analysis value C 16 H 15 F 2 NO 5 Calculated value C56.64, H4.46, N4.13 Analysis value C56.51, H4.44, N4.02 Add 1.7 g of the above compound to 100 ml of dichloromethane and cool on ice. A solution of 6.0 g of aluminum bromide dissolved in 10 ml of ethanethiol was added to the solution. After returning to room temperature and stirring for 3 hours, the solvent was distilled off, ice water was added to the residue, and insoluble matter was filtered off. The obtained white powder was recrystallized from a mixture of chloroform and ethanol to give 9,10-difluoro-3-hydroxymethyl-7-oxo-2,3 as microneedles with a melting point of 268-270°C.
-dihydro-7H-pyrido[1,2,3-de]
1.1 g of ethyl [1,4]benzoxazine-6-carboxylate was obtained.

元素分析値 C15H13F2NO5として 計算値 C55.39,H4.03,N4.31 分析値 C55.66,H4.23,N4.29 上記化合物400mgをクロロホルム30mlに溶かし
塩化チオニル3mlを加えて4時間還流した。反応
液を減圧乾固し、残渣をクロロホルムに溶かして
水、炭酸水素ナトリウム水溶液及び水で順次洗い
芒硝で乾燥した。溶媒を留去し、残渣をクロロホ
ルムとエタノールの混液から再結晶し、融点250
〜251℃の微針晶として3−クロロメチル−9,
10−ジフルオロ−7−オキソ−2,3−ジヒドロ
−7H−ピリドー[1,2,3−de][1,4]ベ
ンゾオキサジン−6−カルボン酸エチル220mgを
得た。
Elemental analysis value C 15 H 13 F 2 NO 5 Calculated value C55.39, H4.03, N4.31 Analysis value C55.66, H4.23, N4.29 Dissolve 400 mg of the above compound in 30 ml of chloroform and add 3 ml of thionyl chloride. In addition, the mixture was refluxed for 4 hours. The reaction solution was dried under reduced pressure, and the residue was dissolved in chloroform, washed successively with water, an aqueous sodium bicarbonate solution, and water, and dried over sodium sulfate. The solvent was distilled off, the residue was recrystallized from a mixture of chloroform and ethanol, and the melting point was 250.
3-chloromethyl-9, as microneedles at ~251°C
220 mg of ethyl 10-difluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate was obtained.

元素分析値 C15H12ClF2NO4として 計算値 C52.42,H3.52,N4.08 分析値 C52.26,H3.45,N4.10 参考例2:抗菌性化合物の製造 実施例で得た化合物200mgを無水ベンゼン30ml
に懸濁し1,8−ジアザビシクロ[5,4,0]
−7−ウンデセン(DBU)230mgを加えて1時間
還流した。冷後反応液にクロロホルムを加えて水
洗し、芒硝で乾燥した。溶媒留去後残渣をシリカ
ゲルカラムクロマトグラフイで精製し、ジクロル
メタンとイソプロピルエーテルの混液から再結晶
すると、融点258〜263℃の9,10−ジフルオロ−
3−メチレン−7−オキソ−2,3−ジヒドロ−
7H−ピリド[1,2,3−de][1,4]ベンゾ
オキサジン−6−カルボン酸エチル120mgが得ら
れた。
Elemental analysis value C 15 H 12 ClF 2 NO 4 Calculated value C52.42, H3.52, N4.08 Analysis value C52.26, H3.45, N4.10 Reference example 2: Production of antibacterial compound In the example 200 mg of the obtained compound was added to 30 ml of anhydrous benzene.
Suspended in 1,8-diazabicyclo[5,4,0]
230 mg of -7-undecene (DBU) was added and the mixture was refluxed for 1 hour. After cooling, chloroform was added to the reaction mixture, washed with water, and dried with Glauber's salt. After evaporating the solvent, the residue was purified by silica gel column chromatography and recrystallized from a mixture of dichloromethane and isopropyl ether to give 9,10-difluoro-
3-methylene-7-oxo-2,3-dihydro-
120 mg of ethyl 7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate was obtained.

NMR(DMSO−d6,δppm) 3位メチレン基;5.47,5.89 (各1H,d,J=2.5Hz) 上記化合物100mgをジメチルスルホキシド3ml
に溶かし、N−メチルピペラジン100mgを加えて
浴温120〜130℃で6時間撹拌した。冷後溶媒を減
圧乾固し、残渣をシリカゲルカラムクロマトグラ
フイで精製した。得た粉末100mgをエタノール10
mlに懸濁し、3%水酸化ナトリウム水溶液1mlを
加えて40〜50℃で30分間撹拌した。反応液を減圧
乾固し、残渣に水を加えて希塩酸で酸性としたの
ち再び炭酸水素ナトリウムで塩基性とし、クロロ
ホルムで抽出した。抽出液は芒硝で乾燥し、溶媒
を留去した。残渣をシリカゲルカラムクロマトグ
ラフイで精製し、エタノールから再結晶すると融
点200〜201℃の微針晶として9−フルオロ−10−
(4−メチル−1−ピペラジニル)−3−メチレン
−7−オキソ−2,3−ジヒドロ−7H−ピリド
[1,2,3−de][1,4]ベンゾオキサジン
−6−カルボン酸25mgが得られた。
NMR (DMSO-d 6 , δppm) Methylene group at 3-position; 5.47, 5.89 (1H, d, J = 2.5Hz each) 100mg of the above compound was dissolved in 3ml of dimethyl sulfoxide.
100 mg of N-methylpiperazine was added thereto, and the mixture was stirred at a bath temperature of 120 to 130°C for 6 hours. After cooling, the solvent was dried under reduced pressure, and the residue was purified by silica gel column chromatography. 100 mg of the obtained powder was mixed with ethanol 10
ml, 1 ml of 3% aqueous sodium hydroxide solution was added, and the mixture was stirred at 40 to 50°C for 30 minutes. The reaction solution was dried under reduced pressure, water was added to the residue, acidified with dilute hydrochloric acid, made basic again with sodium bicarbonate, and extracted with chloroform. The extract was dried with Glauber's salt and the solvent was distilled off. The residue was purified by silica gel column chromatography and recrystallized from ethanol to give 9-fluoro-10- as microneedles with a melting point of 200-201°C.
25 mg of (4-methyl-1-piperazinyl)-3-methylene-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid Obtained.

Claims (1)

【特許請求の範囲】 1 式 (式中R1は低級アルキル基を意味し、R2は低
級アルコキシル基、ヒドロキシル基またはハロゲ
ン原子を意味する)で表わされる化合物。
[Claims] 1 formula (In the formula, R 1 means a lower alkyl group, and R 2 means a lower alkoxyl group, a hydroxyl group, or a halogen atom).
JP20544189A 1989-08-08 1989-08-08 3-substituted pyridobenzoxazine Granted JPH02138281A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20544189A JPH02138281A (en) 1989-08-08 1989-08-08 3-substituted pyridobenzoxazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20544189A JPH02138281A (en) 1989-08-08 1989-08-08 3-substituted pyridobenzoxazine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57112040A Division JPS591489A (en) 1982-06-29 1982-06-29 Pyridobenzoxazine derivative

Publications (2)

Publication Number Publication Date
JPH02138281A JPH02138281A (en) 1990-05-28
JPH0317838B2 true JPH0317838B2 (en) 1991-03-11

Family

ID=16506931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20544189A Granted JPH02138281A (en) 1989-08-08 1989-08-08 3-substituted pyridobenzoxazine

Country Status (1)

Country Link
JP (1) JPH02138281A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3487083B2 (en) * 1996-02-09 2004-01-13 日立化成工業株式会社 Thermosetting resin composition and cured product thereof

Also Published As

Publication number Publication date
JPH02138281A (en) 1990-05-28

Similar Documents

Publication Publication Date Title
JP2520549B2 (en) Fluorocyclopropyl amino acrylate derivative
JPH0148911B2 (en)
JPH027314B2 (en)
JPH0317838B2 (en)
JPH0116837B2 (en)
JPH0374671B2 (en)
JPH0518816B2 (en)
WO2000015596A1 (en) Processes for the preparation of fluorinated benzoic acids
JPH0331710B2 (en)
PL81422B1 (en) 2-chloro-7-hydroxy-11-(1-piperazinyl)dibenz(b f)(1 4)oxazepines[us3660406a]
JPS6257636B2 (en)
JPH08208591A (en) 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates
JPS6256154B2 (en)
JPS585902B2 (en) β↓-nitrostyrene derivative
JPS5872588A (en) Production of pyrido(1,2,3-de)-1,4-benzoxazine derivative
JPH039095B2 (en)
JPH024222B2 (en)
JPH0359904B2 (en)
JPS5823693A (en) Imidazoquinoxaline compounds
JPH0158186B2 (en)
JPS5852290A (en) Pyridobenzoxazinecarboxylic acid derivative
JPS61271292A (en) 3-fluoromethyl-pyridobenzoxazine derivative
JPS6379874A (en) Isoindole derivative
JPS604824B2 (en) Indazole derivative
JPS6139312B2 (en)